Cynthia E. Keen[email protected]Radiation Oncology/TherapyNew studies hint that APBI could be used in more patientsAccelerated partial-breast irradiation (APBI) has carved out a niche as a valuable tool in treating low-risk patients with early-stage breast cancer. But could the technique also have a role in patients at increased risk? Maybe, according to a set of recent clinical studies.December 21, 2009Radiation Oncology/TherapyVA lowers estimate of patients affected by brachytherapy mistakesOfficials from the U.S. Department of Veterans Affairs (VA) last week said that fewer patients than originally estimated were affected by alleged errors during brachytherapy treatments at a Philadelphia VA facility. At the same time, VA officials also apologized for the treatment mistakes.December 20, 2009Radiation Oncology/TherapyAuntMinnie.com Radiation Oncology InsiderDecember 16, 2009Radiation Oncology/TherapyHigher RT dose improves outcomes for prostate cancer patientsIntermediate-risk prostate cancer patients show better outcomes with newer high-dose-rate radiation therapy (RT) procedures compared to patients who received conventional-dose 3D conformal radiation therapy, according to an article published this month in Cancer.December 13, 2009ISHealthcare IT tackles contrast events in RSNA sessionsThe impressive capabilities of healthcare informatics to collect, query, and analyze patient and treatment-related data are starting to be understood and utilized with respect to improving the quality and safety of diagnostic imaging services. Nowhere was this more apparent than in several presentations at the 2009 RSNA show.December 10, 2009MRIMRI in the OR: Impact on pediatric neurosurgical proceduresThe use of intraoperative MRI during pediatric neurosurgery is enabling Canadian surgeons to perform less-invasive procedures by allowing them to modify the surgical plan midsurgery.December 7, 2009ISAuntMinnie.com Healthcare IT InsiderDecember 6, 2009ISRadiology reports: What do physicians really want?CHICAGO - What do referring physicians think of the radiology reports they receive, and how do they use them? Radiologists at Hershey Medical Center in Hershey, PA, conducted a survey to find out whether the reports they prepared met the needs of clinicians who received them.December 2, 2009Radiation Oncology/TherapyPatients develop moderate distortion after breast cancer brachytherapyCHICAGO - The majority of breast cancer patients who received MammoSite balloon brachytherapy treatment developed symptoms of moderate breast distortion within two years of treatment, according to an RSNA presentation on Tuesday.December 1, 2009ISFree library of best-practice report templates published by RSNACHICAGO - In conjunction with its annual meeting, the RSNA has published a free downloadable library of radiology report templates representing the "best-practice" recommendations of more than 100 experts from 12 radiology specialties.December 1, 2009Previous PagePage 63 of 88Next PageTop StoriesCTNew benchmark helps monitor cumulative CT radiation doseThe findings highlight the need for systematic dose tracking and rigorous justification of imaging.Radiation Oncology/TherapyStudy questions routine use of radiotherapy after bone surgeryUltrasoundCEUS outshines color Doppler imaging for indeterminate kidney lesionsWomens ImagingWomen's Imaging MinnieCast, Episode 2: Risk-based vs. annual mammography screening, part 1Digital X-RayChest x-rays reveal atherosclerosis in patients undergoing amputations
![Images depict axial MRI scans in a 50-year-old premenopausal female patient with biopsy-proven 12-mm invasive lobular cancer in the lower outer quadrant of the left breast. Upper images are subtracted dynamic contrast-enhanced (DCE) MRI scans from the first and second postcontrast acquisitions. Lower images are ultrafast MRI scans obtained within 24 hours after the DCE study (four consecutive subtracted dynamic frames from time points [T] 6–9). There is marked background parenchymal enhancement (BPE) on the DCE MRI scans. Thus, the known cancer (arrow) is barely visible; it exhibits only slightly stronger enhancement than the normal fibroglandular tissue, which results in low conspicuity. At ultrafast MRI there is less BPE, and still the cancer is barely visible because it starts to enhance simultaneously with the BPE. The conspicuity of the cancer is even reduced compared with the DCE series. Both of the readers missed this cancer on both the DCE and ultrafast MRI scans.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2025/05/2025-05-06-rsna-ultrafast-dce-mri-breast.Gzvq76udFr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
